Metraipolis › archive › dc_bb562a3876bb

The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism — Europe PMC PMID:41908060

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41908060
DOI: 10.3389/fcvm.2026.1773664
License (as archived): solo-consultazione
Archived: 2026-11-04T10:06:33.694Z
SHA-256 of the archived text: baaa63ff75baabc3192e75f010ac74f3e2c994fd3b2eb8eb90b09cd0df50f54d
Stable URL of this page: https://metraipolis.com/documento/dc_bb562a3876bb

How to cite

The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism — Europe PMC PMID:41908060 — Europe PMC (en), https://europepmc.org/article/MED/41908060 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb562a3876bb (Metraipolis archive dc_bb562a3876bb, sha256 baaa63ff75baabc3192e75f010ac74f3e2c994fd3b2eb8eb90b09cd0df50f54d)

BibTeX

@misc{dcbb562a3876bb,
  title = {The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism — Europe PMC PMID:41908060},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41908060},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb562a3876bb; sha256 baaa63ff75baabc3192e75f010ac74f3e2c994fd3b2eb8eb90b09cd0df50f54d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41908060. Agents can read the archived copy with the MCP tool read_document.